Literature DB >> 15198525

Artificial neural network as an alternative to multiple regression analysis in optimizing formulation parameters of cytarabine liposomes.

Narayanaswamy Subramanian1, Archit Yajnik, Rayasa S Ramachandra Murthy.   

Abstract

The objective of the study was to optimize the formulation parameters of cytarabine liposomes by using artificial neural networks (ANN) and multiple regression analysis using 3(3) factorial design (FD). As model formulations, 27 formulations were prepared. The formulation variables, drug (cytarabine)/lipid (phosphatidyl choline [PC] and cholesterol [Chol]) molar ratio (X1), PC/Chol in percentage ratio of total lipids (X2), and the volume of hydration medium (X3) were selected as the independent variables; and the percentage drug entrapment (PDE) was selected as the dependent variable. A set of causal factors was used as tutorial data for ANN and fed into a computer. The optimization was performed by minimizing the generalized distance between the predicted values of each response and the optimized one that was obtained individually. In case of 3(3) factorial design, a second-order full-model polynomial equation and a reduced model were established by subjecting the transformed values of independent variables to multiple regression analysis, and contour plots were drawn using the equation. The optimization methods developed by both ANN and FD were validated by preparing another 5 liposomal formulations. The predetermined PDE and the experimental data were compared with predicted data by paired t test, no statistically significant difference was observed. ANN showed less error compared with multiple regression analysis. These findings demonstrate that ANN provides more accurate prediction and is quite useful in the optimization of pharmaceutical formulations when compared with the multiple regression analysis method.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15198525      PMCID: PMC2784849          DOI: 10.1208/pt050104

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  13 in total

1.  Application of neural computing in pharmaceutical product development.

Authors:  A S Hussain; X Q Yu; R D Johnson
Journal:  Pharm Res       Date:  1991-10       Impact factor: 4.200

2.  Defined media optimization for growth of recombinant Escherichia coli X90.

Authors:  L Yee; H W Blanch
Journal:  Biotechnol Bioeng       Date:  1993-01-20       Impact factor: 4.530

Review 3.  Artificial neural network as a novel method to optimize pharmaceutical formulations.

Authors:  K Takayama; M Fujikawa; T Nagai
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

4.  Relating formulation variables to in vitro dissolution using an artificial neural network.

Authors:  N K Ebube; T McCall; Y Chen; M C Meyer
Journal:  Pharm Dev Technol       Date:  1997-08       Impact factor: 3.133

5.  Formulation optimization of indomethacin gels containing a combination of three kinds of cyclic monoterpenes as percutaneous penetration enhancers.

Authors:  K K Levison; K Takayama; K Isowa; K Okabe; T Nagai
Journal:  J Pharm Sci       Date:  1994-09       Impact factor: 3.534

6.  Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine.

Authors:  T M Allen; T Mehra; C Hansen; Y C Chin
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

7.  Low-dose cytosine arabinoside in the myelodysplastic syndromes and acute myelogenous leukemia.

Authors:  J D Roberts; W B Ershler; B H Tindle; J A Stewart
Journal:  Cancer       Date:  1985-09-01       Impact factor: 6.860

8.  Response surface optimization of the critical medium components for the production of alkaline protease by a newly isolated Bacillus sp.

Authors:  K Adinarayana; P Ellaiah
Journal:  J Pharm Pharm Sci       Date:  2002 Sep-Dec       Impact factor: 2.327

9.  Low dose cytosine arabinoside (Ara C) in myelodysplastic syndromes.

Authors:  G Tricot; R De Bock; A W Dekker; M A Boogaerts; M Peetermans; K Punt; R L Verwilghen
Journal:  Br J Haematol       Date:  1984-10       Impact factor: 6.998

10.  Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties.

Authors:  Y Zou; Y H Ling; N T Van; W Priebe; R Perez-Soler
Journal:  Cancer Res       Date:  1994-03-15       Impact factor: 12.701

View more
  5 in total

1.  Experimental design for the formulation and optimization of novel cross-linked oilispheres developed for in vitro site-specific release of Mentha piperita oil.

Authors:  Wilbert Sibanda; Viness Pillay; Michael P Danckwerts; Alvaro M Viljoen; Sandy van Vuuren; Riaz A Khan
Journal:  AAPS PharmSciTech       Date:  2004-03-12       Impact factor: 3.246

2.  Modified nanoprecipitation method for preparation of cytarabine-loaded PLGA nanoparticles.

Authors:  Khushwant S Yadav; Krutika K Sawant
Journal:  AAPS PharmSciTech       Date:  2010-09-15       Impact factor: 3.246

3.  Predictive models for maximum recommended therapeutic dose of antiretroviral drugs.

Authors:  Michael Lee Branham; Edward A Ross; Thirumala Govender
Journal:  Comput Math Methods Med       Date:  2012-02-28       Impact factor: 2.238

4.  Systematically optimized topical delivery system for Loperamide hydrochloride: Formulation design, in vitro and in vivo biopharmaceutical evaluation.

Authors:  Jianhui Shu; Jingjing Zhao; Fang Guo
Journal:  Asian J Pharm Sci       Date:  2017-08-31       Impact factor: 6.598

Review 5.  State-of-the-Art Review of Artificial Neural Networks to Predict, Characterize and Optimize Pharmaceutical Formulation.

Authors:  Shan Wang; Jinwei Di; Dan Wang; Xudong Dai; Yabing Hua; Xiang Gao; Aiping Zheng; Jing Gao
Journal:  Pharmaceutics       Date:  2022-01-13       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.